ArticleBiomedical reports2025

Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease.

Hideki Mizuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.